Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2019 / Cilt: 53 - Sayı: 3

Investigation of Extra-Uterine Tumor Dissemination of Endometrial Cancers with Myometrial Invasion Less Than 50% According to Histologic Subtypes

Pages
252–255
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A comprehensive staging surgery should be planned for these patients, regardless of the depth of myometrial invasion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate the rates of extra-uterine metastases of non-endometrioid endometrial tumors limited to the half of the myometrium.
📊
Key Findings & Data:Methods: Patients operated for endometrial cancer between 2005-2015 in two gynecologic oncology centers were screened from clinical archives.
💡
Conclusion & Impact:A comprehensive staging surgery should be planned for these patients, regardless of the depth of myometrial invasion.
🔬Design:Research Article
📍Scope:2005-2015 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: This study aims to investigate the rates of extra-uterine metastases of non-endometrioid endometrial tumors limited to the half of the myometrium. Methods: Patients operated for endometrial cancer between 2005-2015 in two gynecologic oncology centers were screened from clinical archives. The inclusion criteria were serous, clear cell, undifferentiated or carcinosarcoma histologies and less than half myometrial invasion. Each histological type was analyzed for adnexal metastasis, lymph node metastasis (pelvic/paraaortic) and omental metastasis. Results: A total of 116 patients with the median age of 64 (34-72) were examined. Of the patients, 57 were serous (49.1%), 29 were clear cell (25.0%), 27 were carcinosarcoma (23.3%) and 3 (2.6%) were undifferentiated histologic type. Adnexal metastasis (over/ tuba) was detected in 15 patients (12.9 %), nodal metastasis in 10 patients (8.6%), and omental metastasis in 15 patients (12.9%). The rates of adnexal metastases were calculated as 14% for serous type, 10% for clear cell type and 11% for carcinosarcoma. Omental metastasis rates were 11% for serous type, 17% for clear cell type and 15% for carcinosarcoma. The rates of extra-peritoneal nodal metastases were calculated as 12% for serous type, 7% for clear cell type and 4% for carcinosarcoma. Conclusion: According to the findings obtained in this study, the rates of extra-uterine metastasis are high for serous, clear cell or carcinosarcoma types even in the early period. However, the lymph node metastasis in the carcinosarcoma seems to be lower. A comprehensive staging surgery should be planned for these patients, regardless of the depth of myometrial invasion.

🔖

Cite This Article

KABAN, A., TOPUZ, S., ERDEM, B., SÖZEN, H., SALİHOĞLU, Y. (2019). Investigation of Extra-Uterine Tumor Dissemination of Endometrial Cancers with Myometrial Invasion Less Than 50% According to Histologic Subtypes. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 53 - Sayı: 3, 252–255. https://ajindex.com/articles/364035

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7–30
  2. UK CR. Worldwide cancer statistics. Cancer Res UK 2014;2012:2012–5
  3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30
  4. Köse MR, Başara BB, Güler C, Yentür GK. Sağlık Bakanlığı İstatistik Yıllığı 2013. Available at: http: // www. sagem.gov.tr. Sağlık Bakanlığı Araştırma Genel Müdürlüğü. Accessed Ankara, 2014
  5. Kosebay D, Beşe T, Ergun E, Demirkıran F, Arvas M, Moin F, et al. Endometrium kanserinde sağkalım ve hastalıksız yaşam süresine etki eden prognostik faktörlerin değerlendirilmesi. Turkiye Klin J Gynecol Obs 1996;6:259–68
  6. Düzgüner S, Ilgın H, Taşçı T, Düzgüner İN, Turan T, Boran N, et al. Miks tip endometrium kanseri analizi. J Turk Soc Obs Gynecol 2014;11:119–25
  7. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366:491–505
  8. Reynaers EA, Ezendam NP, Pijnenborg JM. Comparable outcome between endometrioid and non-endometrioid tumors in patientswith early-stage high-grade endometrial cancer. J Surg Oncol 2015;111:790–4
  9. Lewin SN. Revised FIGO staging system for endometrial cancer. Clin Obstet Gynecol 2011;54:215–8
  10. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. Int J Gynecol Cancer 2016;26:2–30
  11. NCCN. NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms. 2015. (
  12. Kaban A, Topuz S, Erdem B, Sozen H, Numanoğlu C, Salihoğlu Y, Is Omentectomy Necessary for Non-Endometrioid Endometrial Cancer. Gynecol Obstet Invest 2018;83:482–486 13. Helpman L, Kupets R, Covens A, Saad RS, Khalifa MA, Ismiil N, Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer. Br J Cancer 2014;110:609– 15
  13. Batista TP, Cavalcanti CL, Tejo AA, Bezerra AL. Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma. Eur J Surg Oncol 2016;42:1367–71
  14. Thanachaiviwat A, Thirapakawong C, Leelaphatanadit C, Chuangsuwanich T. J Med Accuracy of preoperative curettage in determining tumor type and grade in endometrial cancer. Assoc Thai 2011;94:766–71
  15. Peled Y, Aviram A, Krissi H, Gershoni A, Sabah G, Levavi H Uterine papillary serous carcinoma pre-operat